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Bridging non-communicable disease 
burden research to clinical care: 
A rising tide or a tidal wave?
To the Editor: There is an increased focus on non-communicable 
diseases (NCDs) in low- and middle-income countries.[1] South 
Africa (SA)’s National Strategic Plan on HIV looks to leverage the 
successes of community-based HIV programmes to build an effective 
NCD continuum of care.[2,3] In early 2015, our research team added 
evidence of the colliding burden of non-infectious and infectious 
diseases in rural KwaZulu-Natal, SA through an integrated home-
based NCD and HIV testing and counselling (HTC) programme.[4] 
As parallels and differences between HIV and NCD programmes are 
being investigated, significant questions arise: (i) What is our ethical 
obligation in HIV- and NCD-integrated screening projects to follow-
up testing and care?; and (ii) Where will the large number of at-risk 
patients go and how will it affect the current HIV programmes?
The benefits of early, integrated screening are clear.[5] Early case 
identification maximises the benefits of lifestyle and pharmacologi-
cal interventions. At the community level, integrated programmes 
may destigmatise HIV and promote a culture of preventive health. 
Furthermore, disease burden research helps policy-makers to set 
priorities and allocate resources. 
We are reminded of the criteria for a justifiable screening 
programme,[6,7] specifically that (i) the costs of the programme must 
justify the benefits; and (ii) resources to run the programme must 
be available. Primum non nocere (first, do no harm) is the basis of 
the ethical principle of non-maleficence. In our study, numerous 
pitfalls arose as we reviewed the timing of the NCD testing and 
counselling relative to HTC. How did the health worker set priorities 
during counselling? What would the impact of NCD counselling 
be if emphasised before HIV counselling in the case of a high-risk 
patient? At what threshold is there diminishing return in broadening 
our counselling? At a systems level, we are challenged in our pursuit 
of distributive justice. Screening to identify high-volume, low-acuity 
NCD cases threatens to overburden an already challenged system. 
In isolation, linkage to care data is unlikely to capture the potential 
harms. Once enrolled, do NCD patients continue through the 
cascade of care? Does the influx of NCD patients draw resources and 
human capital away from higher-acuity HIV or tuberculosis (TB) 
cases? Is it ethical to focus on community-based NCD counselling 
and delay clinic referral that may potentially harm the system? 
We propose the following principles to preserve the responsibility 
of guaranteeing benefit to the community: (i) a capacity assessment 
of the NCD care cascade should be conducted, aligned to the 
stability of coexisting HIV and TB programmes; (ii) the screening 
programme should be coupled with interventions to minimise the 
overburdening of clinics, including community-based strategies for 
lifestyle modifications and support groups, and potentially to initiate 
therapy with medications, which raises the question of funding, as US 
federal funds restrict ancillary care or capacity building (outside the 
scope of this letter);[8] (iii) integrated screening programmes should 
support a steady rise rather than a flood of new patients; and (iv) 
the need to strengthen impact evaluations to provide feedback and 
ensure that integration brings more benefit than harm to the systems 
on which we build.
I Golovaty 
Department of Medicine, University of Washington, Seattle, WA, USA
ilyamg@uw.edu
A van Heerden, Z Essack, H van Rooyen
Human Sciences Research Council, Pretoria, South Africa
R Barnabas 
Department of Medicine, and Departments of Global Health and Epidemiology, 
University of Washington, Seattle, WA; and Vaccine and Infectious Diseases Division, 
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
1. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury 
attributable to 67 risk factors and risk factor clusters in 21 regions, 1990 - 2010: A systematic analysis 
for the Global Burden of Disease Study 2010. Lancet 2012;380(9859):2224-2260. http://dx.doi.org/ 
10.1016/S0140-6736(12)61766-8
2. United Nations Programme on HIV/AIDS. Global AIDS response progress report. 2012. http://www.
unaids.org/sites/default/files/country/documents//ce_ZA_Narrative_Report.pdf (accessed 20 April 
2017).
3. Ministry of Health. Strategic plan for the prevention and control of non-communicable diseases 2013 - 17. 2013. 
http://www.hsrc.ac.za/uploads/pageContent/3893/NCDs%20STRAT%20PLAN%20%20CONTENT%20
8%20april%20proof.pdf (accessed 26 April 2017).
4. Van Heerden A, Barnabas R, Norris S, Micklesfield L. Integrating non-communicable disease (NCD) 
screening and referral to care into home HIV testing and counseling in rural KwaZulu-Natal, South 
Africa: Burden of disease. International AIDS Conference, 18 - 22 July 2016, Durban, South Africa. 
http://repository.hsrc.ac.za/handle/20.500.11910/10129 (accessed 28 April 2017).
5. Checkley W, Ghannem H, Irazola V, et al. Management of NCD in low- and middle-income countries. 
Glob Heart 2014;9(4):431-443. http://dx.doi.org/10.1016/j.gheart.2014.11.003
6. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical Epidemiology: A Basic Science for Clinical 
Medicine. 2nd ed. Boston: Little, Brown, 1991:154-170.
7. Ewart R. Primum non nocere and the quality of evidence: Rethinking the ethics of screening. J Am 
Board Fam Pract 2000;13(3):188-196.
8. Philpott S, Slevin K, Shapiro K, Lori H. Impact of donor-imposed requirements and restrictions on 
standards of prevention and access to care and treatment in HIV prevention trials. Public Health Ethics 
2010;3:220-228. http://dx.doi.org/10.1093/phe/phq027
S Afr Med J 2017;107(6):467. DOI:10.7196/SAMJ.2017.v107i6.12495
This open-access article is distributed under 
Creative Commons licence CC-BY-NC 4.0.
